XML 28 R79.htm IDEA: XBRL DOCUMENT v2.4.0.6
Selected Quarterly Financial Data (Detail) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Revenues:                      
Research and development programs $ 3,811 $ 4,810 $ 9,468 $ 9,560 $ 8,251 $ 7,051 $ 6,092 $ 5,399      
Product revenue 4,613 3,773 4,077 3,996 1,638 1,886 1,306 2,343 16,459 7,173  
License fees         5,000         5,000 15,000
Total revenues 8,424 8,583 13,545 13,556 14,889 8,937 7,398 7,742 44,108 38,966 37,970
Costs and operating expenses:                      
Cost of product revenue 1,404 1,331 1,330 1,246 828 554 374 664 5,311 2,420  
Research and development 16,108 16,534 18,381 15,361 16,921 10,866 9,676 8,150 66,384 45,613 34,227
Sales, general and administrative 15,888 13,849 13,723 14,056 12,835 11,527 10,955 6,109 57,516 41,426 17,422
Total costs and operating expenses 33,400 31,714 33,434 30,663 30,584 22,947 21,005 14,923 129,211 89,459 51,649
Loss from operations (24,976) (23,131) (19,889) (17,107) (15,695) (14,010) (13,607) (7,181) (85,103) (50,493) (13,679)
Other income (expense):                      
Interest and other income (expense), net 249 626 309 327 114 (76) (184) 375      
Loss from equity method investment (631) (683) (510)           (1,824)    
Gain (loss) from change in fair value of warrant liability 748 685 851       (3,154) (483) 2,284 (3,637) (2,638)
Total other income (expense) 366 628 650 327 114 (76) (3,338) (108) 1,971 (3,408) (2,601)
Net loss (24,610) (22,503) (19,239) (16,780) (15,581) (14,086) (16,945) (7,289) (83,132) (53,901) (16,280)
Accretion of redeemable convertible preferred stock             (24) (36)   60 140
Net loss attributable to Solazyme, Inc. common stockholders $ (24,610) $ (22,503) $ (19,239) $ (16,780) $ (15,581) $ (14,086) $ (16,969) $ (7,325) $ (83,132) $ (53,961) $ (16,420)
Net loss per share attributable to Solazyme, Inc. common stockholders:                      
Basic and diluted $ (0.40) $ (0.37) $ (0.32) $ (0.28) $ (0.26) $ (0.24) $ (0.61) $ (0.60) $ (1.37) $ (1.35) $ (1.42)
Weighted-average number of shares used in loss per share computation:                      
Basic and diluted 60,873,000 60,678,000 60,378,000 60,101,000 59,703,000 59,508,000 27,673,000 12,160,000 60,509,048 39,934,013 11,540,494